BioWorld MedTech

Jan. 2, 2015

Aetna passes on tests for rheumatoid arthritis made by Crescendo, Exagen

Aetna (Hartford, Connecticut) wrapped up the year with a couple of empty holiday gift boxes addressed to Crescendo Bioscience (South San Francisco, California) and Exagen Diagnostics (Vista, California). Read More

Avacen launches $2M campaign to launch device clinical trials

FDA deems cardiac support system, dental devices misbranded for claims

Venezuela signs $117M maintenance contract with an Argentina company

HTG Molecular Diagnostics plans to raise up to $60 million in IPO

Physician reaches milestone with SuperPath Hip technique

BayCare Health System uses Clairifire solution to enhance patient service

Keeping you up to date on recent developments in diagnostics

Today's news in brief

BioWorld

BioWorld briefs for March 31, 2026.

Emerging therapeutic strategies for Parkinson’s at ADPD 2026

BioWorld

Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...

With improved technologies, biomarkers, failed drugs may come into their own

BioWorld

At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...

Comparison of neurons in a healthy brain and nerve cells in neurodegenerative disease with amyloid plaques

Small-molecule TREM2 agonist advances to treat Alzheimer’s

BioWorld Science

Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...

News in brief

BioWorld Asia

BioWorld Asia briefs for March 31, 2026